Nalaganje...
Is Insurance a Barrier to HIV Preexposure Prophylaxis? Clarifying the Issue
Clinical trials have demonstrated that preexposure prophylaxis (PrEP) protects against HIV infection; yet, even with its approval by the Food and Drug Administration (FDA) in 2012, less than 10% of eligible users in the United States are currently taking PrEP. While there are multiple factors that i...
Shranjeno v:
| izdano v: | Am J Public Health |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Public Health Association
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6893325/ https://ncbi.nlm.nih.gov/pubmed/31725314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2105/AJPH.2019.305389 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|